These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
16. Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Argyriou AA; Makris N Acta Neurol Scand; 2008 Oct; 118(4):209-17. PubMed ID: 18336627 [TBL] [Abstract][Full Text] [Related]
17. [Prognostic value of aquaporin-4 antibody in patients of inflammatory demyelinating diseases in central nervous system]. Yang Y; Wu WP; Huang DH; Wu L Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(43):3032-5. PubMed ID: 23328372 [TBL] [Abstract][Full Text] [Related]
18. Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Papadopoulos MC; Bennett JL; Verkman AS Nat Rev Neurol; 2014 Sep; 10(9):493-506. PubMed ID: 25112508 [TBL] [Abstract][Full Text] [Related]
19. A review of the current literature and a guide to the early diagnosis of autoimmune disorders associated with neuromyelitis optica. Iyer A; Elsone L; Appleton R; Jacob A Autoimmunity; 2014 May; 47(3):154-61. PubMed ID: 24512514 [TBL] [Abstract][Full Text] [Related]
20. Neuromyelitis optica: an overview. Nandhagopal R; Al-Asmi A; Gujjar AR Postgrad Med J; 2010 Mar; 86(1013):153-9. PubMed ID: 20237009 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]